We can’t show the full text here under this license. Use the link below to read it at the source.
Status and influential factors of anxiety depression and insomnia symptoms in the work resumption period of COVID-19 epidemic: A multicenter cross-sectional study
Anxiety, depression, and insomnia symptoms and their key influences during COVID-19 work reopening: A multicenter survey
AI simplified
Abstract
19.5% to 21.7% of participants reported symptoms of anxiety, depression, or insomnia during the work resumption period of COVID-19.
- 2.9% to 5.6% of participants experienced severe symptoms of anxiety, depression, or insomnia.
- Combined symptoms of anxiety-depression, anxiety-insomnia, or depression-insomnia were reported by 2.4%, 4.8%, and 4.5% of participants, respectively.
- Positive correlations were observed between anxiety and insomnia scores, as well as between depression and insomnia scores.
- Participants aged 50-64 years and those who engaged in outdoor activities at least once in 30 days were identified as risk factors for these psychological symptoms.
- Only 17.4% of participants received psychological interventions during the epidemic, with just 5.2% receiving individual interventions.
AI simplified